Sign in

CIK 0001662579

  • Non-accelerated filer
  • Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475617627
Phone
+1 617-231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$122,487
in 1 filing, $122K under 10b5-1 plans

Net −$122,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Adams Kendra −$122K Chief Financial Officer sold 12% of stake
Date Insider Transaction Shares Price Value Owned after
2026-02-14 Mossler Mark Chief Accounting Officer Exercise or conversion +9,420 75,184
2026-02-14 Mossler Mark Chief Accounting Officer Shares withheld for taxes −3,268 $1.89 $6K 71,916
2026-02-13 Mossler Mark Chief Accounting Officer Grant or award +56,980 75,184
2025-02-14 Mossler Mark Chief Accounting Officer Shares withheld for taxes −1,586 $3.18 $5K 18,204
2024-02-14 Mossler Mark Chief Accounting Officer Grant or award +18,290 19,790
2024-02-14 Mossler Mark Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +27,430 27,430

Page 1 of 1 · 6 trades